The private equity firm’s bid for Vectura remains lower than that made by PMI. Read More
The move underlines the company’s commitment to Canada, says CEORead More
The action affects more than two-thirds of all PMTA products under review. Read More
Some sellers are still holding significant volumes of now-illicit stock. Read More
The studies will help establish a scientific basis for Poda's products as cessation tools.Read More
But they should be combined with other antismoking measures, say researchers. Read More
The acquisition is the company’s third non-tobacco deal in short succession. Read More
The move comes after a counteroffer from Carlyle for the drug delivery solutions provider. Read More
Smoker group says such a measure would only drive tobacco underground. Read More
Investors fear a regulatory crackdown by Chinese authorities. Read More
Recent Posts
- Quebec Lobby Groups Blind to Illicit Trade: Imperial
- Sales Down, Profit up at Turning Point Brands
- Vector Group Reports First-Quarter Results
- U.S. DEA Asks White House to Reclassify Marijuana
- The Great Scramble
- A Perfect Storm
- Real-World Quitting
- Japan Tobacco to Keep Russian Business
- Support for Filter Ban at Plastics-Pollution Summit
- The Path Less Traveled
- Smart and Smooth
- Feeling the Squeeze
- Driving Transformation
- Doubling Down on Failure
- Dan Gallagher President Smoker Friendly